Pharmacin, established in 2016, is a pharmaceutical company specializing in advanced formulation technologies to support the development of 505(b)(2) drug products, repurposed therapies, and new chemical entities (NCEs). Leveraging its proprietary platforms to improve bioavailability and drug developability, Pharmacin revitalizes shelved compounds and accelerates their path to the clinic. In addition to progressing its own pipeline, the company collaborates with biotech partners to tackle formulation challenges for complex NCEs. With headquarters in Shenzhen and operations in Suzhou and New Haven, Pharmacin combines R&D, CMC, and business development expertise to drive efficient, high-value drug development for global markets.